Transcriptional activation of fucosyltransferase (FUT) genes using the CRISPR-dCas9-VPR technology reveals potent N-glycome alterations in colorectal cancer cells. (22nd October 2018)

• Record Type: Journal Article
• Authors: Blanas, Athanasios; Cornelissen, Lenneke A M; Kotsias, Maximilianos; van der Horst, Joost C; van de Vrugt, Henri J; Kalay, Hakan; Spencer, Daniel I R; Kozak, Rad P; van Vliet, Sandra J
• Is Part Of: Glycobiology. Volume 29:Number 2(2019)
• Page Start: 137
• Page End: 150
• Publication Date: 2018-10-22
• Subjects: colorectal cancer -- CRISPR-dCas9-VPR -- fucosylation -- gene activation -- N-glycans; Glycoproteins -- Periodicals; Glycolipids -- Periodicals; Glycoconjugates -- Periodicals; 572.567
• DOI: 10.1093/glycob/cwy096
• Languages: English
• ISSNs: 0959-6658

Abstract

Abstract: Aberrant fucosylation in cancer cells is considered as a signature of malignant cell transformation and it is associated with tumor progression, metastasis and resistance to chemotherapy. Specifically, in colorectal cancer cells, increased levels of the fucosylated Lewis x antigen are attributed to the deregulated expression of pertinent fucosyltransferases, like fucosyltransferase 4 (FUT4) and fucosyltransferase 9 (FUT9). However, the lack of experimental models closely mimicking cancer-specific regulation of fucosyltransferase gene expression has, so far, limited our knowledge regarding the substrate specificity of these enzymes and the impact of Lewis x synthesis on the glycome of colorectal cancer cells. Therefore, we sought to transcriptionally activate the Fut4 and Fut9 genes in the well-known murine colorectal cancer cell line, MC38, which lacks expression of the FUT4 and FUT9 enzymes. For this purpose, we utilized a physiologically relevant, guide RNA-based model of de novo gene expression, namely the CRISPR-dCas9-VPR system. Induction of the Fut4 and Fut9 genes in MC38 cells using CRISPR-dCas9-VPR resulted in specific neo-expression of functional Lewis x antigen on the cell surface. Interestingly, Lewis x was mainly carried by N -linked glycans in both MC38-FUT4 and MC38-FUT9 cells, despite pronounced differences in the biosynthetic properties and the expression stability of the induced enzymes. Moreover, Lewis x expression was found to influence core-fucosylation, sialylation, antennarity and the subtypes of N -glycans in the MC38-glycovariants. In conclusion, exploiting the CRISPR-dCas9-VPR system to augment glycosyltransferase expression is a promising method of transcriptional gene activation with broad application possibilities in glycobiology and oncology research.